Human IgE against the major allergen Bet v 1 - defining an epitope with limited cross-reactivity between different PR-10 family proteins

Clinical and Experimental Allergy

Volumn 44, Issue 2, 2014, Pages 288-299

  Levin, M ^a   Davies, A M ^b,c   Liljekvist, M ^a   Carlsson, F ^a   Gould, H J ^b,c   Sutton, B J ^b,c   Ohlin, M ^a  

^a LUND UNIVERSITY   (Sweden)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Allergy; Antibodies; Epitopes; Molecular biology

Indexed keywords

ALLERGEN; AMINO ACID; ANTIBODY; IMMUNOGLOBULIN E; PR 10 PROTEIN; RECOMBINANT ALLERGEN; RECOMBINANT BET V 1; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG;

ALLERGIC REACTION; ARTICLE; CROSS REACTION; HUMAN; HUMAN CELL; IMMUNOASSAY; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; X RAY CRYSTALLOGRAPHY;

ALLERGY; ANTIBODIES; EPITOPES; MOLECULAR BIOLOGY;

AMINO ACID SEQUENCE; ANTIGENS, PLANT; CROSS REACTIONS; CRYSTALLOGRAPHY, X-RAY; EPITOPES; HEK293 CELLS; HUMANS; IMMUNOGLOBULIN E; MOLECULAR SEQUENCE DATA; PLANT PROTEINS; SINGLE-CHAIN ANTIBODIES;

EID: 84892720206     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12230     Document Type: Article

References (62)

1. Gould HJ, Sutton BJ, Beavil AJ et al. The biology of IgE and the basis of allergic disease. Annu Rev Immunol 2003; 21:579-628.
2. Gould HJ, Sutton BJ. IgE in allergy and asthma today. Nat Rev Immunol 2008; 8:205-17.
3. Finkelman FD, Vercelli D. Advances in asthma, allergy mechanisms, and genetics in 2006. J Allergy Clin Immunol 2007; 120:544-50.
4. Coker HA, Harries HE, Banfield GK et al. Biased use of VH5 IgE-positive B cells in the nasal mucosa in allergic rhinitis. J Allergy Clin Immunol 2005; 116:445-52.
5. H5 gene segments of a patient with asthma: implications for IgE. Eur J Immunol 1997; 27:162-70.
6. Snow RE, Djukanovic R, Stevenson FK. Analysis of immunoglobulin E VH transcripts in a bronchial biopsy of an asthmatic patient confirms bias towards VH5, and indicates local clonal expansion, somatic mutation and isotype switch events. Immunology 1999; 98:646-51.
7. Edwards MR, Brouwer W, Choi CHY, Ruhno J, Ward RL, Collins AM. Analysis of IgE antibodies from a patient with atopic dermatitis: biased V gene usage and evidence for polyreactive IgE heavy chain complementarity-determining region 3. J Immunol 2002; 168:6305-13.
8. Andréasson U, Flicker S, Lindstedt M et al. The human IgE-encoding transcriptome to assess antibody repertoires and repertoire evolution. J Mol Biol 2006; 362:212-27.
9. Persson H, Sadegh MK, Greiff L, Ohlin M. Delineating the specificity of an IgE-encoding transcriptome. J Allergy Clin Immunol 2007; 120:1186-92.
10. Persson H, Flicker S, Sadegh MK, Greiff L, Valenta R, Ohlin M. A common idiotype in IgE and its relation to recognition of the grass pollen allergen Phl p 2. Mol Immunol 2008; 45:2715-20.
11. Kerzel S, Rogosch T, Struecker B, Maier RF, Zemlin M. IgE transcripts in the circulation of allergic children reflect a classical antigen-driven B cell response and not a superantigen-like activation. J Immunol 2010; 185:2253-60.
12. Levin M, Tan LW, Baker L, Wormald P-J, Greiff L, Ohlin M. Diversity of immunoglobulin E-encoding transcripts in sinus mucosa of subjects diagnosed with non-allergic fungal eosinophilic sinusitis. Clin Exp Allergy 2011; 41:811-20.
13. Wang Y, Jackson KJL, Chen Z et al. IgE sequences in individuals living in an area of endemic parasitism show little mutational evidence of antigen selection. Scand J Immunol 2011; 73:496-504.
14. Gould HJ, Takhar P, Harries HE, Chevretton E, Sutton BJ. The allergic march from Staphylococcus aureus superantigens to immunoglobulin E. Chem Immunol Allergy 2007; 93:106-36.
15. Wagner S, Radauer C, Bublin M et al. Naturally occurring hypoallergenic Bet v 1 isoforms fail to induce IgE responses in individuals with birch pollen allergy. J Allergy Clin Immunol 2008; 121:246-52.
16. Smole U, Balazs N, Hoffmann-Sommergruber K et al. Differential T-cell responses and allergen uptake after exposure of dendritic cells to the birch pollen allergens Bet v 1.0101, Bet v 1.0401 and Bet v 1.1001. Immunobiology 2010; 215:903-9.
17. Flicker S, Steinberger P, Ball T et al. Spatial clustering of the IgE epitopes on the major timothy grass pollen allergen Phl p 1: importance for allergenic activity. J Allergy Clin Immunol 2006; 117:1336-43.
18. Levin M, Rydnert F, Källström E et al. Phl p 1-specific human monoclonal IgE and design of a hypoallergenic group 1 grass pollen allergen fragment. J Immunol 2013;191:551-60.
19. D'Amato G, Cecchi L, Bonini S et al. Allergenic pollen and pollen allergy in Europe. Allergy 2007; 62:976-90.
20. Radauer C, Lackner P, Breiteneder H. The Bet v 1 fold: an ancient, versatile scaffold for binding of large, hydrophobic ligands. BMC Evol Biol 2008; 8:286.
21. IUIS Allergen Nomenclature Sub-Committee website (http://www.allergen.org/viewallergen.php?aid=129) (Last accessed 4 June 2013)
22. Holm J, Gajhede M, Ferreras M et al. Allergy vaccine engineering: epitope modulation of recombinant Bet v 1 reduces IgE binding but retains protein folding pattern for induction of protective blocking-antibody responses. J Immunol 2004; 173:5258-67.
23. Persson H, Wallmark H, Ljungars A, Hallborn J, Ohlin M. In vitro evolution of an antibody fragment population to find high-affinity hapten binders. Protein Eng Des Sel 2008; 21:485-93.
24. Braren I, Blank S, Seismann H et al. Generation of human monoclonal allergen-specific IgE and IgG antibodies from synthetic antibody libraries. Clin Chem 2007; 53:837-44.
25. Brochet X, Lefranc M-P, Giudicelli V. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res 2008; 36:W503-8.
26. Lefranc M-P, Pommié C, Ruiz M et al. IMGT unique numbering for immunoglobulin and T cell receptor variable domains and Ig superfamily V-like domains. Dev Comp Immunol 2003; 27:55-77.
27. Kabsch W. XDS. Acta Crystallogr D Biol Crystallogr 2010; 66:125-32.
28. Winter G. xia2: an expert system for macromolecular crystallography data reduction. J Appl Crystallogr 2010; 43:186-90.
29. Winn MD, Ballard CC, Cowtan KD et al. Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol Crystallogr 2011; 67:235-42.
30. Vagin A, Teplyakov A. MOLREP: an Automated Program for Molecular Replacement. J Appl Crystallogr 1997; 30:1022-5.
31. Canul-Tec JC, Riaño-Umbarila L, Rudiño-Piñera E, Becerril B, Possani LD, Torres-Larios A. Structural basis of neutralization of the major toxic component from the scorpion Centruroides noxius Hoffmann by a human-derived single-chain antibody fragment. J Biol Chem 2011; 286:20892-900.
32. Adams PD, Afonine PV, Bunkóczi G et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 2010; 66:213-21.
33. Emsley P, Lohkamp B, Scott WG, Cowtan K. Features and development of Coot. Acta Crystallogr D Biol Crystallogr 2010; 66:486-501.
34. Chen VB, Arendall WB, Headd JJ et al. MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D Biol Crystallogr 2010; 66:12-21.
35. Urzhumtseva L, Afonine PV, Adams PD, Urzhumtsev A. Crystallographic model quality at a glance. Acta Crystallogr D Biol Crystallogr 2009; 65:297-300.
36. Evans P. Scaling and assessment of data quality. Acta Crystallogr D Biol Crystallogr 2006; 64:72-82.
37. Boyd SD, Gaëta BA, Jackson KJ et al. Individual variation in the germline Ig gene repertoire inferred from variable region gene rearrangements. J Immunol 2010; 184:6986-92.
38. Venet S, Ravn U, Buatois V et al. Transferring the characteristics of naturally occurring and biased antibody repertoires to human antibody libraries by trapping CDRH3 sequences. PLoS ONE 2012; 7:e43471.
39. Ferreira F, Hirtenlehner K, Jilek A et al. Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy. J Exp Med 1996; 183:599-609.
40. Mirza O, Henriksen A, Ipsen H et al. Dominant epitopes and allergic cross-reactivity: complex formation between a Fab fragment of a monoclonal murine IgE antibody and the major allergen from birch pollen Bet v 1. J Immunol 2000; 165:331-8.
41. Hecker J, Diethers A, Schulz D et al. An IgE epitope of Bet v 1 and fagales PR10 proteins as defined by a human monoclonal IgE. Allergy 2012; 67:1530-7.
42. The PyMOL Molecular Graphics System, Version 1.3. Schrödinger, LLC.
43. Lebecque S, Dolecek C, Laffer S et al. Immunologic characterization of monoclonal antibodies that modulate human IgE binding to the major birch pollen allergen Bet v 1. J Allergy Clin Immunol 1997; 99:374-84.
44. Lund G, Willumsen N, Holm J, Christensen LH, Würtzen PA, Lund K. Antibody repertoire complexity and effector cell biology determined by assays for IgE-mediated basophil and T-cell activation. J Immunol Methods 2012; 383:4-20.
45. Gieras A, Cejka P, Blatt K et al. Mapping of conformational IgE epitopes with peptide-specific monoclonal antibodies reveals simultaneous binding of different IgE antibodies to a surface patch on the major birch pollen allergen, Bet v 1. J Immunol 2011; 186:5333-44.
46. Padavattan S, Flicker S, Schirmer T et al. High-affinity IgE recognition of a conformational epitope of the major respiratory allergen Phl p 2 as revealed by X-ray crystallography. J Immunol 2009; 182:2141-51.
47. Niemi M, Jylhä S, Laukkanen M-L et al. Molecular interactions between a recombinant IgE antibody and the β-lactoglobulin allergen. Structure 2007; 15:1413-21.
48. Gajhede M, Osmark P, Poulsen FM et al. X-ray and NMR structure of Bet v 1, the origin of birch pollen allergy. Nat Struct Biol 1996; 3:1040-5.
49. Schweimer K, Sticht H, Nerkamp J et al. NMR spectroscopy reveals common structural features of the birch pollen allergen Bet v 1 and the cherry allergen Pru a 1. Appl Magn Reson 1999; 17:449-64.
50. Ferreira F, Ebner C, Kramer B et al. Modulation of IgE reactivity of allergens by site-directed mutagenesis: potential use of hypoallergenic variants for immunotherapy. FASEB J 1998; 12:231-42.
51. Paar JM, Harris NT, Holowka D, Baird B. Bivalent ligands with rigid double-stranded DNA spacers reveal structural constraints on signaling by Fc epsilon RI. J Immunol 2002; 169:856-64.
52. Hunt J, Keeble AH, Dale RE et al. A fluorescent biosensor reveals conformational changes in human IgE Fc: implications for mechanisms of receptor binding, inhibition and allergen recognition. J Biol Chem 2012; 287:17459-70.
53. Schöll I, Kalkura N, Shedziankova Y et al. Dimerization of the major birch pollen allergen Bet v 1 is important for its in vivo IgE-cross-linking potential in mice. J Immunol 2005; 175:6645-50.
54. Rouvinen J, Jänis J, Laukkanen M-L. Transient dimers of allergens. PLoS ONE 2010; 5:e9037.
55. Christensen LH, Holm J, Lund G, Riise E, Lund K. Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge. J Allergy Clin Immunol 2008; 122:298-304.
56. Burton DR, Barbas CF 3rd, Persson MA et al. A large array of human monoclonal antibodies to type 1 human immunodeficiency virus from combinatorial libraries of asymptomatic seropositive individuals. Proc Natl Acad Sci USA 1991; 88:10134-7.
57. Steinberger P, Kraft D, Valenta R. Construction of a combinatorial IgE library from an allergic patient. Isolation and characterization of human IgE Fabs with specificity for the major timothy grass pollen allergen, Phl p 5. J Biol Chem 1996; 271:10967-72.
58. H is sufficient for most antibody specificities. Immunity 2000; 13:37-45.
59. Aalberse RC, Crameri R. IgE-binding epitopes: a reappraisal. Allergy 2011; 66:1261-74.
60. Thomson CA, Bryson S, Mclean R, Creagh AL, Pai EF, Schrader JW. Germline V-genes sculpt the binding site of a family of antibodies neutralizing human cytomegalovirus. EMBO J 2008; 27:2592-602.
61. Zwick MB, Komori HK, Stanfield RL et al. The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-Human Immunodeficiency Virus type 1 antibody 2F5. J Virol 2004; 78:3155-61.
62. Saphire EO, Parren PW, Pantophlet R et al. Crystal structure of a neutralizing human IgG against HIV-1: a template for vaccine design. Science 2001; 293:1155-9.